ExpreS2ion will participate in key industry and investor events
Hørsholm, Denmark, May 24, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and hold presentations at key industry and investor events in the coming month. These include an Oncology webinar (May 31) and presentation of Q1 2022 results (June 9), both hosted by H.C. Andersen Capital, the ECI Vaccine Technology VIII conference (June 12-17) and the world’s largest biotech conference, the BIO International Convention (June 13-16).By attending relevant industry and investor events, the company aims to increase the awareness of the